At Roche the prime objective is to provide healthcare solutions which deliver superior options for diagnosis and treatment to clinicians and ultimately the patients.
The personalised healthcare approach delivers on this objective. This approach uses new molecular insights and molecular diagnostics tests to better tailor medicines and better manage diseases. Roche aims at tailoring medicine as closely as possible to patients’ needs. As one of the world’s leading healthcare companies, and given the combined strengths in pharmaceuticals and diagnostics, no company is better suited for this task.
Personalised healthcare has enormous potential to make healthcare better, safer, and more cost-effective.
It will still be some time before the potential of personalised healthcare is fully realised, but the market is clearly shifting away from "one size fits all" products.
Over the last few years, Roche has provided various examples of how interweaving diagnostic and pharmaceutical expertise paves the way for personalised healthcare. Our goal is to provide healthcare professionals with more powerful diagnostic tools and targeted treatments based on the new insights into how disease arises at the molecular level.